Warburg Pincus related stories
All articles and analysis
Side Letter: KKR's $8bn close; 5x continuation vindication; CalSTRS' two-pronged climate planKKR has closed its latest European flagship. Plus: How CalSTRS aims to deploy billions into climate investing; and the SEC is taking a closer look at third-party valuations. Here’s today's brief, for our valued subscribers only.
ArchiMed scores 300x return for debut fund with Polyplus exitArchiMed and Warburg Pincus have agreed to sell the France-headquartered business to life science group Sartorius for approximately €2.4bn.
Thinking of launching an RMB strategy? Here's what you need to knowLegal experts outline what foreign GPs entering China's domestic PE market should expect in terms of LP composition, fund terms and the burgeoning QFLP scheme.
PEI Awards 2022: SecondariesThe top secondaries firms, advisers, deals and law firms of the year, as voted by PEI readers
Side Letter: Obliterating PE's J-curve; Chinese PE's SEA change; European LevFin tipsArkansas' $10 billion public pension has made a bold and logical move in adding PE to its stable. Plus: why China's reopening could have implications for Southeast Asian PE markets and what you need to know about European leveraged finance. Here’s today's brief, for our valued subscribers only.
Private equity and PRI: Agreement in principlesAs regulation and voluntary initiatives start to create alignment around ESG expectations in private equity, we explore how the Principles for Responsible Investment maintains its allure.
Side Letter: Introducing PEI's performance data; Warburg's $15bn; Africa's Adenia exclusiveWondering how a fund has performed? PEI has you covered. Plus: Warburg Pincus is nearing the final close on its latest flagship; and Africa's Adenia Partners smashes prior raise. Here’s today's brief, for our valued subscribers only.
Healthy return: Five questions on Mubadala's life sciences playbookDemographic shifts and the rising cost of care in Asia have boosted interest in the market, according to the SWF’s head of life sciences for direct investments in America.
Why are buyout firms undeterred by the tech downturn?Falling valuations are failing to cool PE appetite for enterprise software.
Side Letter: Nordic PE's P2P opportunity; LPs' priorities in GP-leds; Permira opens in IndiaNordic PE dealflow isn't the party it used to be. Plus: Misalignment in continuation fund deals and PE execs see a wealth of opportunities in the UK. Here's today's brief, for our valued subscribers only.